MarketWatch Dr. Lambotte brings over 25 years of product development leadership in the area of POC in-vitro diagnostic technologies, Lateral Flow Immunoassay, and Molecular Platform development. During his ... 更多 »
PR Newswire (press release) Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche's personalized healthcare strategy aims at providing ... 更多 »
The Christian Times ... that previously could not use this technology," said Alberto Gutierrez, director of the Office of In Vitro Diagnostics and Radiological Health ...
Nasdaq TUCSON, Ariz., Jan. 7, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug ... 更多 »
GenomeWeb Last year, a global diagnostic player entered the field, new laboratories in the US and abroad launched NIPT services and several providers announced their plans to develop in vitro diagnostic NIPT ...
生物谷 “SCID is a fatal disease that can be treated with early intervention， including screening，” said Alberto Gutierrez， Ph.D.， director of the Office of In Vitro Diagnostics and Radiological Health in ...
GenomeWeb Last November, Sequenta struck a deal with Illumina to commercialize an in vitro diagnostic kit based on Sequenta's MRD detection and quantification technology, which will be carried over in the ... Adaptive Biotechnologies Acquires Sequenta GenomeWeb 此专题所有 7 篇报道 »
Regulatory Focus The proposed Drugs and Cosmetics (Amendment) Bill, 2015 would adopt definitions of medical devices as well as in vitro diagnostic (IVD) products more ...
Digital Journal Market Research Reports, Inc. has announced the addition of “ In Vitro Diagnostics Market in India 2014” research report to their offering. Lewes, DE -- (ReleaseWire) -- 12/23/2014 -- In Vitro Diagnostics ... 更多 »
PR Newswire (press release) NEW YORK, Dec. 15, 2014 /PRNewswire/ -- The Australian in vitro diagnostics (IVD) market is comfortably out-performing its counterpart IVD ...
